文献速递银屑病与炎症性皮肤病

一款支持银屑病患者的智能手机应用可改善外用治疗依从性:一项随机对照试验

A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial.
PubMed 文献 · Br J Dermatol · 2018-07-05

干预组第4周依从率高于无干预组(65% vs 38%,P=0.004),LS-PGA降幅更大(均值1.86 vs 1.46,P=0.047);第8周和第26周效果相似但未达统计学显著。

要点

  • 干预组第4周依从率65%,无干预组38%(P=0.004)。
  • 干预组第4周LS-PGA降幅均值1.86,无干预组1.46(P=0.047)。
  • 第8周和第26周效果相似但未达统计学显著。

核心结论

  • 该随机对照试验表明,应用改善了Cal/BD泡沫剂治疗的短期依从性和银屑病严重程度。

研究设计与样本

  • 随机对照试验(RCT,clinicaltrials.gov注册号NCT02858713)。
  • 患者接受每日一次Cal/BD泡沫剂,随机分为无应用组(n=66)和应用干预组(n=68)。
  • 共122例患者(91%)完成22周随访。
  • 主要结局为依从性,定义为治疗期间用药天数≥80%,通过药物分配器中集成的芯片评估。
  • 次要结局为银屑病严重程度(LS-PGA)和生活质量(DLQI),在所有访视时评估。

主要发现

  • 第4周干预组对Cal/BD泡沫剂依从的患者多于无干预组(65% vs 38%,P=0.004)。
  • 第4周干预组LS-PGA降幅大于无干预组(均值1.86 vs 1.46,P=0.047)。
  • 第8周和第26周效果相似,但未达统计学显著。

关键数值与推荐

  • 依从性定义为治疗期间用药天数≥80%。
  • 主要结局依从性通过药物分配器中集成的芯片评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adherence to topical psoriasis treatments is low, which leads to unsatisfactory treatment results. Smartphone applications (apps) for patient support exist but their potential to improve adherence has not been systematically evaluated. OBJECTIVES: To evaluate whether a study-specific app improves adherence and reduces psoriasis symptoms compared with standard treatment. METHODS: We conducted a randomized controlled trial (RCT, clinicaltrials.gov registration: NCT02858713). Patients received once-daily medication [calcipotriol/betamethasone dipropionate (Cal/BD) cutaneous foam] and were randomized to no app (n = 66) or app intervention (n = 68) groups. In total, 122 patients (91%) completed the 22-week follow-up. The primary outcome was adherence, which was defined as medication applied ≥ 80% of days during the treatment period and assessed by a chip integrated into the medication dispenser. Secondary outcomes were psoriasis severity measured by the Lattice System Physician's Global Assessment (LS-PGA) and quality of life, measured using the Dermatology Life Quality Index (DLQI) at all visits. RESULTS: Intention-to-treat analyses using regression was performed. More patients in the intervention group were adherent to Cal/BD cutaneous foam than those in the nonintervention group at week 4 (65% vs. 38%, P = 0·004). The intervention group showed a greater LS-PGA reduction than the nonintervention group at week 4 (mean 1·86 vs. 1·46, P = 0·047). A similar effect was seen at weeks 8 and 26, although it did not reach statistical significance. CONCLUSIONS: This RCT demonstrates that the app improved short-term adherence to Cal/BD cutaneous foam treatment and psoriasis severity.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Svendsen MT, Andersen F, Andersen KH, et al. A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial. Br J Dermatol. 2018. PMID: 29654699. doi:10.1111/bjd.16667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。